欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
IT/H/1080/001
药品名称
Faberka 2,5 mg, filmomhulde tabletten
活性成分
Tadalafil 2.5 mg
剂型
Film-coated tablet
上市许可持有人
Centrafarm B.V. Nieuwe Donk 3 4879 AC Etten Leur The Netherlands
参考成员国 - 产品名称
Italy (IT)
互认成员国 - 产品名称
Netherlands (NL)
许可日期
2020/04/16
最近更新日期
2025/12/02
药物ATC编码
G04BE08 tadalafil
申请类型
TypeLevel1：
TypeLevel2：
TypeLevel3：
TypeLevel4：
TypeLevel5：
附件文件下载
Final Product Information
|
EOP PL_Tadalafil_10mg_NL4706_8
Date of last change:2024/09/06
Final Product Information
|
EOP PL_Tadalafil_2_5mg_NL4706_8_
Date of last change:2024/09/06
Final Product Information
|
EOP PL_Tadalafil_20mg_NL4706_8
Date of last change:2024/09/06
Final Product Information
|
EOP PL_Tadalafil_5mg_NL4706_8
Date of last change:2024/09/06
Final Product Information
|
EOP SmPC_Tadalafil_10mg_NL4706_8_
Date of last change:2024/09/06
Final Product Information
|
EOP SmPC_Tadalafil_2_5mg_NL4706_8
Date of last change:2024/09/06
Final Product Information
|
EOP SmPC_Tadalafil_20mg_NL4706_8_
Date of last change:2024/09/06
Final Product Information
|
EOP SmPC_Tadalafil_5mg_NL4706_8_
Date of last change:2024/09/06
PubAR
|
PAR_4706_DC_tadalafil_9 jul 2020
Date of last change:2024/09/06
PubAR Summary
|
PAR_4706_DC_tadalafil_9 jul 2020_summary Eng
Date of last change:2024/09/06
Final PL
|
PL_Cinacalcet_NL4342_20211103_clean_PL_Cinacalcet_NL4342_20211103_clean
Date of last change:2024/09/06
Final PL
|
PL_Fluoxetine_NL354_202111_AD_cl_PL_Fluoxetine_NL354_202111_AD_cl
Date of last change:2024/09/06
Final PL
|
PL_Risperidone_NL918_clean_PL_Risperidone_NL918_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase